Altos Labs company information, Employees & Contact Information

Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming ScienceDirect.com

Altos Labs launches with the goal to transform medicine through cellular rejuvenation programming PR Newswire

ESGCT 2025: Altos Labs’ Scientific Founder Targets ‘Mesenchymal Drift’ in Efforts to Combat Diseases of Aging Genetic Engineering and Biotechnology News

PERK-ATAD3A interaction provides a subcellular safe haven for protein synthesis during ER stress Science | AAAS

Announcing Altos Labs as Tier 5 Sponsor of ARDD 2024 EurekAlert!

Editorial: The connections of immune metabolic mechanisms with aging-related diseases Frontiers

Cyclophilin D plays a critical role in the survival of senescent cells EMBO Press

Targeted evolution of adeno-associated virus capsids for systemic transgene delivery to microglia and tissue-resident macrophages PNAS

Degron-Based bioPROTACs for Controlling Signaling in CAR T Cells ACS Publications

Despite blockbuster Altos funding, longevity-focused investment drops by $1B: report Fierce Biotech

Meet Altos Labs, Silicon Valley’s latest wild bet on living forever MIT Technology Review

Altos Labs Announces Sponsored Research Agreement with Kyoto University's CiRA to Foster Cellular Rejuvenation Programming Research PR Newswire

Aberrant cortical spine dynamics after concussive injury are reversed by integrated stress response inhibition PNAS

Altos Labs Announces Skip Virgin as Chief Medical Officer and Head of the Altos Institute of Medicine PR Newswire

Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging Science | AAAS

Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning Science | AAAS

Altos bursts out of stealth with $3B, a dream team C-suite and a wildly ambitious plan to reverse disease Fierce Biotech

ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo EMBO Press

HNRNPH1 regulates the neuroprotective cold‐shock protein RBM3 expression through poison exon exclusion EMBO Press

Hexosamine pathway activation improves memory but does not extend lifespan in mice - Allmeroth - 2022 - Aging Cell Wiley Online Library

Altos Labs hires a new medical chief with mTOR experience, Novartis chops Endpoints News

Altos Labs launches with $3 billion for cellular rejuvenation Chemical & Engineering News

Biotech Altos Labs emerges with $3B in funding to focus on 'cellular rejuvenation programming' drugdiscoverytrends.com

Altos Labs Launches with $3B and a Focus on Reversing Disease, Aging Genetic Engineering and Biotechnology News

Altos Labs insists mission is to improve lives not cheat death Financial Times

10 start-ups on a mission to extend lives Swiss Life-Gruppe

Jeff Bezos-backed, lifespan-focused Altos Labs buys small biotech with Stanford roots The Business Journals

Jeff Bezos has invested in an anti-aging biotech startup, a report says businessinsider.com

Altos Labs launches AI and computational biology institute Longevity.Technology

Jeff Bezos has reportedly invested in anti-aging startup Altos Labs New York Post

Altos Labs acquires Dorian Therapeutics BeBeez International

Inside Altos Labs: the biotech titan cracking the code to the elixir of youth Yahoo! Australia

Lessons from the Minimal Cell Genetic Engineering and Biotechnology News

Silicon Valley start-up funded by billionaires hires top ‘anti-aging’ experts EL PAÍS English

Exclusive | Behind the billionaire-backed longevity business — and the innovations that could help us live longer New York Post

Startup Altos Labs launches with $3B, with GSK exec to take helm BioWorld MedTech

Jeff Bezos Invests in Anti-Aging Biotech Startup Altos Labs Market Realist

Billionaires Are Hiring Top Doctors, Nobel Prize Laureates to Help Them Live Forever observer.com

Inside Altos Labs’ $3 Billion Quest to Defy Ageing, Backed by Jeff Bezos Sri Lanka Guardian

Jeff Bezos Is Paying For a Way to Make Humans Immortal Popular Mechanics

First space, now immortality: Jeff Bezos’ quest to cheat death Euronews.com

Jeff Bezos’ Altos Labs to Defeat Death Green Prophet

Altos Labs launches Cambridge Institute of Science with cellular rejuvenation mission Cambridge Independent

Bezos billions fund new antiaging biotech start-up (possibly) Longevity.Technology